Skip to main content

High-grade Splenic Injuries

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Penumbra
PenumbraALAMEDA, CA
1 program
Splenic artery embolization with vascular embolic coils or plugsN/A1 trial
Active Trials
NCT05128955Recruiting250Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
PenumbraSplenic artery embolization with vascular embolic coils or plugs

Clinical Trials (1)

Total enrollment: 250 patients across 1 trials

NCT05128955PenumbraSplenic artery embolization with vascular embolic coils or plugs

Embolization of the Splenic Artery After Trauma

Start: May 2022Est. completion: Dec 2026250 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 250 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.